369P Irinotecan is superior to oxaliplatin in KRAS-G12C-mutated (K-G12C-m) colorectal cancer (CRC) and should be preferred in combination strategies with K-G12C inhibitors. A multicenter propensity score-matched (PSM) retrospective analysis

Subjects

Subjects :

Oncology
Hematology

Details

ISSN :

09237534

Volume :

33

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........8dd64495a2d8aae001f02a6a6853d1f0

Full Text :

https://doi.org/10.1016/j.annonc.2022.07.507